Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis

NMR in Biomedicine

Volumn 13, Issue 2, 2000, Pages 57-63

  Cucurella, Maria Gracia ^a   Rovira, Alex ^a,b   Río, Jordi ^b   Pedraza, Salvador ^a,b   Tintoré, Maria Mar ^b   Montalbán, Xavier ^b   Alonso, Julio ^a,b  

^a Institut de Diagnostic per la Imatge   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

1H NMR; Brain; Human; Multiple sclerosis; Nuclear magnetic resonance

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHOSPHOCREATINE;

ILEX COOKII;

EID: 0034013736     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(200004)13:2<57::AID-NBM609>3.0.CO;2-5     Document Type: Article

References (19)

1. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994; 117: 759-765.
2. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DPE, McDonald WI. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann. Neurol. 1991; 29: 53-62.
3. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, Montalbán X, De Sá J. Primary progressive multiple sclerosis. Brain 1997; 120: 1085-1096.
4. Arnold DL, Matthews PM, De Stefano N. MRI and proton MRS in the evaluation of multiple sclerosis. In Magnetic Resonance Spectroscopy and Imaging in Neurochemistry, Volume 8 of Advances in Neurochemistry, Bachelard HS (ed); Plenum Press: New York, 1997; 267-288.
5. Richards TL Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. Am. J. Roentgenol. 1991; 157: 1073-1078.
6. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 1983; 13: 227-231.
7. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann. NY Acad. Sci. 1987; 508: 333-348.
8. IH NMR chemical shift selective (CHESS) imaging. Phys. Med. Biol. 1985; 30: 341-344.
9. Van den Boogaart A, Vanhamme L. MRUI Manual v. 96.3. A User's Guide to the Magnetic Resonance User Interface Software Package. Delft Technische Universiteit Press: Delft, 1997.
10. Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J. Magn. Reson. 1976; 24: 71-85.
11. IH NMR spectroscopy in Canavan's disease: a report of two cases. Magn. Reson. Med. 1991; 19: 439-445.
12. IH NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 1991; 4: 47-52.
13. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J. Neurol. 1994; 241: 354-371.
14. IH magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 1997; 63: 736-742.
15. Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, Antel JP, Wolfson C, Arnold DL. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998; 121: 103-113.
16. Sarchielli P, Presciutti O, Pelliccioli GP, Tarducci R, Gobbi G, Chiarini P, Alberti A, Vicinanza F, Gallai V. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis. Brain 1999; 122: 513-521.
17. Falini A, Calabrese G, Filipi M, Origgi D, Lipari S, Colombo B, Comi G, Scotti G. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. Am. J. Neuroradiol. 1998; 19: 223-229.
18. Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus D, Brennan A, Tofts PS, Thompson AJ, McDonald WI, Miller DH. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann. Neurol. 1994; 36: 62-67.
19. Filippi M, Iannucci G, Tortorella C, Minicucci L, Horsfield MA, Colombo B, Sormani MP, Comi G. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999; 52: 588-594.